Merck & Co., Inc. (NYSE:MRK) is Eliot Finkel Investment Coun

Eliot Finkel Investment Counsel LLC cut its stake in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 68,070 shares of the company’s stock after selling 1,390 shares during the quarter. Merck […]

Related Keywords

Steven Mizell , Joseph Romanelli , Gardasil , Societe Generale , Vitalstone Financial , Cantor Fitzgerald , Animal Health , Exchange Commission , Ruedi Wealth Management Inc , Merck Co , Insider Transactions At Merck Co Inc , Merck Co Inc , Wealth Advisors , Quarter For Merck Co Inc , Wealth Partners , Ameliora Wealth Management Ltd , Eliot Finkel Investment Counsel , News Ratings For Merck Co , Free Report , Finkel Investment Counsel , Wealth Management , Get Free Report , Live Oral , Visit Holdingschannel , Nyse Mrk , Mrk , Medical , 58933y10 , Sec Filings , 13f , Hedge Fund Holdings , Institutional Investor Holdings ,